Phibro Animal Health Corporation (PAHC) Market Cap & Valuation Ratios
Phibro Animal Health Corporation (PAHC) has a market cap of $1.6B, a trailing P/E of 15.9 and a price-to-sales ratio of 1.0, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PAHCPhibro Animal Health CorporationFollow PAHC — free
—
Price chart with a free account
- Market cap
- 1.6B
- P/E TTM
- 15.9
- Dividend yield
- 1.2%
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
Peers
drug manufacturers - specialty & generic · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| PAHC | 1.6 | 15.9 | 1.5 | 9.1 | 0.6% | +17% | 13% | 14% |
| PBH | 2.3 | 13.4 | 3.8 | 13.0 | 10.4% | -1% | 26% | 6% |
| PRGO | 2.2 | — | 1.2 | — | 5.4% | -4% | -38% | -24% |
| TRLV | 2.0 | — | 1.7 | — | 9.3% | -4% | -24% | -27% |
| BCRX | 2.0 | — | 2.1 | — | 19.1% | +69% | -33% | — |
| XERS | 1.9 | — | 5.9 | 52.5 | 3.0% | +36% | 11% | 28% |
| ANIP | 1.7 | 15.7 | 2.0 | 8.1 | 10.4% | +31% | 15% | 13% |
| PCRX | 1.5 | 104.1 | 2.1 | 14.9 | 12.4% | +6% | 3% | 2% |
| ETON | 1.4 | — | 13.5 | 68.6 | 1.0% | +81% | 15% | 42% |
| CRON | 1.2 | 16.9 | 2.4 | 36.9 | 4.0% | +37% | -1% | -0.5% |
| AMPH | 1.1 | 14.9 | 1.9 | 8.1 | 14.3% | +1% | 16% | 8% |
| Median of these 10 | 15.7 | 2.1 | 14.9 | 9.8% | +18% | 7% | 6% |
P/E 15.9 vs. a peer median of 15.7; EV/Sales 1.5 vs. 2.1. PAHC's own P/E sits at the 32nd percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesPRGO and TRLV and BCRX and XERS and ETON have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Phibro Animal Health Corporation — questions
- What is Phibro Animal Health Corporation's market cap?
- $1.6B.
- What is Phibro Animal Health Corporation's P/E ratio?
- 15.9 on trailing twelve-month earnings to 2026-06-30.
- What is Phibro Animal Health Corporation's price-to-sales ratio?
- 1.0.
Every figure on this page comes from Phibro Animal Health Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.